DK1162985T3 - Matrixproteinsammensætninger til induktion af apoptose - Google Patents

Matrixproteinsammensætninger til induktion af apoptose

Info

Publication number
DK1162985T3
DK1162985T3 DK00906552T DK00906552T DK1162985T3 DK 1162985 T3 DK1162985 T3 DK 1162985T3 DK 00906552 T DK00906552 T DK 00906552T DK 00906552 T DK00906552 T DK 00906552T DK 1162985 T3 DK1162985 T3 DK 1162985T3
Authority
DK
Denmark
Prior art keywords
apoptosis
induction
matrix protein
protein compositions
enamel matrix
Prior art date
Application number
DK00906552T
Other languages
English (en)
Inventor
Stale Petter Lyngstadaas
Lars Hammarstroem
Stina Gestrelius
Original Assignee
Biora Bioex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora Bioex Ab filed Critical Biora Bioex Ab
Application granted granted Critical
Publication of DK1162985T3 publication Critical patent/DK1162985T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK00906552T 1999-03-10 2000-03-09 Matrixproteinsammensætninger til induktion af apoptose DK1162985T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199900336 1999-03-10

Publications (1)

Publication Number Publication Date
DK1162985T3 true DK1162985T3 (da) 2004-06-14

Family

ID=8092394

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906552T DK1162985T3 (da) 1999-03-10 2000-03-09 Matrixproteinsammensætninger til induktion af apoptose

Country Status (8)

Country Link
EP (1) EP1162985B1 (da)
JP (1) JP2002538211A (da)
AT (1) ATE258801T1 (da)
AU (1) AU2821000A (da)
DE (1) DE60008077T2 (da)
DK (1) DK1162985T3 (da)
ES (1) ES2215027T3 (da)
WO (1) WO2000053196A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140191D1 (de) * 2000-06-20 2009-11-26 Straumann Inst Ag Zusammensetzungen mit matrixproteinen zur regeneration von dentin
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
AU2005315253B2 (en) 2004-12-10 2011-07-21 Straumann Holding Ag Protein formulation
WO2011051457A2 (en) 2009-11-02 2011-05-05 Straumann Holding Ag Purified emd protein composition
WO2011073447A1 (en) 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
WO2012049324A2 (en) 2010-10-15 2012-04-19 Straumann Holding Ag New emd formulation comprising pga
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672032A (en) * 1983-11-09 1987-06-09 University Of Southern California Dental enamel production

Also Published As

Publication number Publication date
JP2002538211A (ja) 2002-11-12
AU2821000A (en) 2000-09-28
ES2215027T3 (es) 2004-10-01
WO2000053196A1 (en) 2000-09-14
EP1162985B1 (en) 2004-02-04
EP1162985A1 (en) 2001-12-19
DE60008077T2 (de) 2004-12-23
DE60008077D1 (de) 2004-03-11
ATE258801T1 (de) 2004-02-15

Similar Documents

Publication Publication Date Title
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
DE69520499T2 (de) Histidine und homohistidine derivate zur verwendung als protein farnesyltransferase hemmstoffe
DK0725790T3 (da) Substituerede tetra- og pentapeptidinhibitorer af proteinfarnesyltransferase
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
DK1556058T3 (da) Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
DK1162985T3 (da) Matrixproteinsammensætninger til induktion af apoptose
DK1185279T3 (da) Midler til behandling af maligne sygdomme ved anvendelse af proteinet YB-1
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
CO4920227A1 (es) Histidina-n-bencil glicinamida sustituida con cicloalquilos .
WO2001023522A3 (en) Compositions and methods for p53-mediated repression of gene expression
NO20020291D0 (no) Preventive og terapeutiske midler for kreft
DE69807166D1 (de) Prostata-spezifische Antigen Inhibitore
GB9723824D0 (en) Cytostatic agents
DE50301954D1 (de) Liposomale formulierungen von phenylalanin-derivaten
UA49216A (uk) Засіб для лікування ускладнень після видалення злоякісних новоутворень шкіри
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien